Skip to main content
. Author manuscript; available in PMC: 2022 Aug 27.
Published in final edited form as: Int J Tuberc Lung Dis. 2022 Feb 1;26(2):96–102. doi: 10.5588/ijtld.21.0487

Table 1.

Individual approaches to defining adolescents and TB disease evaluation and management

graphic file with name nihms-1830503-t0003.jpg
*

Inline graphic = country had a definition of adolescent separate from that of children; Inline graphic = country defined children 0–14 without separation from adolescents.

†

Inline graphic = required/highly recommended bacteriologic confirmation for TB disease diagnosis; Inline graphic = allowed clinical diagnosis without emphasis on bacteriologic confirmation.

‡

Inline graphic = CXR regarded as an important supplemental test; Inline graphic = CXR recommended as an initial test; Inline graphic = CXR recommended if bacteriologic confirmation unavailable.

§

Inline graphic = TST (or IGRA) is not recommended as part of TB disease evaluation; Inline graphic = TST (or IGRA) is recommended as part of TB disease evaluation.

Inline graphic = transition to adult dosing if weight >25 kg; Inline graphic = only maximum doses are mentioned; Inline graphic = transition to adult dosing based on age cut-off; Inline graphic = transition to adult dosing based on a combination of age and/or weight cut-off.

#

Inline graphic = HIV screening is recommended for all TB patients; Inline graphic = HIV screening is recommended for TB patients with risk factors for HIV or in high prevalence areas; Inline graphic = no specific mention.

CXR = chest X-ray; TST = tuberculin skin test; IGRA = interferon-gamma release assay; CAR = Central African Republic; DPR = Democratic People’s Republic; DR = Democratic Republic; PNG = Papua New Guinea.